Terms: = Prostate cancer AND NPM1, NPM, 4869, ENSG00000181163, P06748, B23, MGC104254
29 results:
1. Focal therapy with high-intensity focused ultrasound for prostate cancer: 3-year outcomes from a prospective trial.
Kaufmann B; Raess E; Schmid FA; Bieri U; Scherer TP; Elleisy M; Donati OF; Rupp NJ; Moch H; Gorin MA; Mortezavi A; Eberli D
BJU Int; 2024 Apr; 133(4):413-424. PubMed ID: 37897088
[TBL] [Abstract] [Full Text] [Related]
2. Stereotactic Body Radiotherapy for Lymph-Nodal Oligometastatic prostate cancer: A Multicenter Retrospective Experience.
Cuccia F; Tamburo M; Piras A; Mortellaro G; Iudica A; Daidone A; Federico M; Zagardo V; Ferini G; Marletta F; Spatola C; Fazio I; Filosto S; Pergolizzi S; Ferrera G
Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629732
[No Abstract] [Full Text] [Related]
3. Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications.
Nilsson C; Linde F; Hulegårdh E; Garelius H; Lazarevic V; Antunovic P; Cammenga J; Deneberg S; Eriksson A; Jädersten M; Björkvall CK; Möllgård L; Wennström L; Ölander E; Höglund M; Juliusson G; Lehmann S
Haematologica; 2023 Apr; 108(4):1015-1025. PubMed ID: 36005563
[TBL] [Abstract] [Full Text] [Related]
4. High expression of npm1 via the Wnt/β-catenin signalling pathway might predict poor prognosis for patients with prostate adenocarcinoma.
Ruan Y; Xu H; Ji X
Clin Exp Pharmacol Physiol; 2022 Apr; 49(4):525-535. PubMed ID: 35108408
[TBL] [Abstract] [Full Text] [Related]
5. Nucleolin and Nucleophosmin Expression in Gleason 3 and Gleason 4 prostate cancer With Seminal Vesicles Invasion (pT3b).
Masiuk M; Lewandowska M; Dobak E; Urasinska E
Anticancer Res; 2020 Apr; 40(4):1973-1979. PubMed ID: 32234886
[TBL] [Abstract] [Full Text] [Related]
6. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
7. Using Serological Proteome Analysis to Identify Serum Anti-Nucleophosmin 1 Autoantibody as a Potential Biomarker in European-American and African-American Patients With prostate cancer.
Dai L; Li J; Xing M; Sanchez TW; Casiano CA; Zhang JY
Prostate; 2016 Nov; 76(15):1375-86. PubMed ID: 27418398
[TBL] [Abstract] [Full Text] [Related]
8. mTOR transcriptionally and post-transcriptionally regulates npm1 gene expression to contribute to enhanced proliferation in cells with Pten inactivation.
Boudra R; Lagrafeuille R; Lours-Calet C; de Joussineau C; Loubeau-Legros G; Chaveroux C; Saru JP; Baron S; Morel L; Beaudoin C
Cell Cycle; 2016 May; 15(10):1352-62. PubMed ID: 27050906
[TBL] [Abstract] [Full Text] [Related]
9. Implication of npm1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer.
Destouches D; Sader M; Terry S; Marchand C; Maillé P; Soyeux P; Carpentier G; Semprez F; Céraline J; Allory Y; Courty J; De La Taille A; Vacherot F
Oncotarget; 2016 Oct; 7(43):69397-69411. PubMed ID: 26993766
[TBL] [Abstract] [Full Text] [Related]
10. Phosphorylation of nucleophosmin at threonine 234/237 is associated with HCC metastasis.
Ching RH; Lau EY; Ling PM; Lee JM; Ma MK; Cheng BY; Lo RC; Ng IO; Lee TK
Oncotarget; 2015 Dec; 6(41):43483-95. PubMed ID: 26536659
[TBL] [Abstract] [Full Text] [Related]
11. Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers.
van der Poel H; Klotz L; Andriole G; Azzouzi AR; Bjartell A; Cussenot O; Hamdy F; Graefen M; Palma P; Rivera AR; Stief CG
World J Urol; 2015 Jul; 33(7):907-16. PubMed ID: 26037891
[TBL] [Abstract] [Full Text] [Related]
12. Intracellular CD24 disrupts the ARF-npm interaction and enables mutational and viral oncogene-mediated p53 inactivation.
Wang L; Liu R; Ye P; Wong C; Chen GY; Zhou P; Sakabe K; Zheng X; Wu W; Zhang P; Jiang T; Bassetti MF; Jube S; Sun Y; Zhang Y; Zheng P; Liu Y
Nat Commun; 2015 Jan; 6():5909. PubMed ID: 25600590
[TBL] [Abstract] [Full Text] [Related]
13. Procyanidin B2 3,3″-di-O-gallate inhibits endothelial cells growth and motility by targeting VEGFR2 and integrin signaling pathways.
Kumar R; Deep G; Wempe MF; Agarwal R; Agarwal C
Curr Cancer Drug Targets; 2015; 15(1):14-26. PubMed ID: 25552257
[TBL] [Abstract] [Full Text] [Related]
14. Preferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigens.
Dai L; Li J; Ortega R; Qian W; Casiano CA; Zhang JY
J Immunol Res; 2014; 2014():827827. PubMed ID: 24860838
[TBL] [Abstract] [Full Text] [Related]
15. npm1 silencing reduces tumour growth and MAPK signalling in prostate cancer cells.
Loubeau G; Boudra R; Maquaire S; Lours-Calet C; Beaudoin C; Verrelle P; Morel L
PLoS One; 2014; 9(5):e96293. PubMed ID: 24796332
[TBL] [Abstract] [Full Text] [Related]
16. Regulatory role of nucleophosmin during the differentiation of human liver cancer cells.
Xu DH; Liu F; Li X; Chen XF; Jing GJ; Wu FY; Shi SL; Li QF
Int J Oncol; 2014 Jul; 45(1):264-72. PubMed ID: 24787960
[TBL] [Abstract] [Full Text] [Related]
17. [Expression of P53, npm1, Kras, c-Myc, p14(ARF) genes in blood cells of cancer patients before and after radiation therapy].
Shulenina LV; Ushenkova LN; Ledin EV; Shagirova ZhM; Raeva NF; Zasukhina GD; Mikhaĭlov VF
Radiats Biol Radioecol; 2012; 52(6):572-81. PubMed ID: 23516888
[TBL] [Abstract] [Full Text] [Related]
18. Identification of differentially expressed proteins in curcumin-treated prostate cancer cell lines.
Teiten MH; Gaigneaux A; Chateauvieux S; Billing AM; Planchon S; Fack F; Renaut J; Mack F; Muller CP; Dicato M; Diederich M
OMICS; 2012 Jun; 16(6):289-300. PubMed ID: 22475723
[TBL] [Abstract] [Full Text] [Related]
19. Influence of gallate esterification on the activity of procyanidin B2 in androgen-dependent human prostate carcinoma LNCaP cells.
Chou SC; Kaur M; Thompson JA; Agarwal R; Agarwal C
Pharm Res; 2010 Apr; 27(4):619-27. PubMed ID: 20162340
[TBL] [Abstract] [Full Text] [Related]
20. Nucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferation.
Brady SN; Maggi LB; Winkeler CL; Toso EA; Gwinn AS; Pelletier CL; Weber JD
Oncogene; 2009 Sep; 28(36):3209-20. PubMed ID: 19561638
[TBL] [Abstract] [Full Text] [Related]
[Next]
